3-acetylpyridine has been researched along with ta 0910 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujitsuka, T; Kinoshita, K; Matsuoka, Y; Yamamura, M | 1 |
| Kinoshita, K; Matsuoka, Y; Watanabe, Y; Yamamura, M | 1 |
| Asai, H; Kinoshita, K; Matsuoka, Y; Watanabe, Y | 1 |
3 other study(ies) available for 3-acetylpyridine and ta 0910
| Article | Year |
|---|---|
Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
Topics: Administration, Oral; Analysis of Variance; Animals; Ataxia; Cerebellum; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gait; Inferior Colliculi; Male; Mice; Mice, Neurologic Mutants; Pyridines; Rats; Rats, Wistar; Spinal Cord Compression; Thoracic Vertebrae; Thyrotropin-Releasing Hormone | 1995 |
TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats.
Topics: Animals; Cerebellar Ataxia; Male; Motor Activity; Niacinamide; Pyridines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone | 1998 |
Metabolic abnormalities caused by 3-acetylpyridine in the cerebral motor regions of rats: partial recovery by thyrotropin-releasing hormone.
Topics: Animals; Blood Pressure; Body Temperature; Brain; Drug Interactions; Glucose; Male; Molecular Mimicry; Neurotoxins; Pyridines; Rats; Rats, Wistar; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone | 2000 |